We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byChristopher Ryan
Modified over 2 years ago
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American Heart Association Get With the Guidelines Program Pamela N. Peterson, MD, MSPH; John S. Rumsfeld, MD, PhD; Li Liang, PhD; Nancy M. Albert, RN, PhD; Adrian F. Hernandez, MD, MHS; Eric D. Peterson, MD, MPH; Gregg C. Fonarow, MD; Frederick A Masoudi, MD, MSPH
© 2010, American Heart Association. All rights reserved. Background HF is a common reason for hospitalization in the United States and a tremendous economic burden. Physicians often miss opportunities to improve the quality of care for their patients hospitalized with HF because they do not calibrate HF therapy to a patients risk for adverse outcomes. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Introduction Risk models may be useful in predicting in-hospital mortality. Patients hospitalized with heart failure (HF) provide a unique setting for the validation of such prognostic information collection. The Get With The Guidelines--HF (GWTG-HF) programs validated risk score has the potential to influence the quality of care provided to patients hospitalized with HF by informing decision making through routinely collected clinical data. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Objective The purpose of this study was to derive and validate a predictive model for in-hospital mortality using readily available clinical data in patients with HF admitted to a GWTG-HF hospital. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
© 2010, American Heart Association. All rights reserved. Methods Between January 2005 and June 2007, data were collected from a cohort of 39,783 patients admitted to 198 GWTG-HF participating hospitals. Potential predictor variables included demo- graphics, co-morbidities, admission laboratory information, vital signs at presentation, and LV systolic dysfunction of 40%. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Results In-hospital death occurred in 1139 (2.86%) patients. Those who died were more likely to have a prior HF diagnosis and an LVEF < 40%, atrial fibrillation, CAD, COPD, anemia and renal insufficiency, higher heart rates, serum creatinine and BUN levels and lower blood pressure, serum sodium and hemoglobin levels on admission, but less likely to have hypertension, hyperlipidemia, or diabetes. Age, systolic blood pressure, BUN level, serum sodium, and heart rate on admission, non--Black race and the presence of COPD were independent predictors of in-hospital death. No significant interactions between left ventricular systolic function and coexisting illnesses were present, indicating that the impact of individual risk factors on outcome was consistent regardless of left ventricular function. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
© 2010, American Heart Association. All rights reserved. Conclusions Age, systolic blood pressure, and BUN level are the admission variables most predictive of in-hospital mortality, with admission heart rate, serum sodium, presence of COPD, and non--Black race contributing modestly. The validated GWTG-HF risk score uses routinely collected data to predict the risk of in-hospital mortality for patients hospitalized with HF. Application of the risk score derived from routine clinical factors collected at the time of admission could influence the quality of care provided to patients hospitalized with HF by informing clinical decision making. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
© 2010, American Heart Association. All rights reserved. Evolving Patterns of Use and Appropriateness of Aldosterone Antagonists in Heart Failure Nancy.
© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
© 2010, American Heart Association. All rights Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality.
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Ovbiagele et al. Epub May 27, Stroke. Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients with Stroke Bruce Ovbiagele,
Associations Between Outpatient Heart Failure Process of Care Measures and Mortality Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade,
2013 ACCF/AHA Guideline for the Management of Heart Failure Developed in Collaboration With the American Academy of Family Physicians, American College.
AHA/ASA Scientific Statement Race-Ethnic Disparities in Stroke Care: The American Experience 0.
Prevalence and Predictors of Off-label Use of Cardiac Resynchronization Therapy: A Report from the ICD Registry TM Adam S. Fein * MD, Yongfei Wang ¥ MS,
J essup et al (2009) Circulation © 2009, American Heart Association. All rights reserved Focused Update: ACC/AHA Guidelines for the Diagnosis and.
Post-discharge Heart Failure Management Ceyhun Ceyhan MD, FESC.
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve Heart Failure Therapies.
Saver et al. Epub June 3, 2010 STROKE The Golden Hour and Acute Brain Ischemia: Presenting Features and Lytic Therapy in Over 30,000 Patients Arriving.
Million Hearts® and Sodium: Best Practices and Opportunities August 22, :00pm - 3:00pm.
0 Based on the 2009 Focused Update Incorporated Into the ACCF/AHA 2005 guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report.
The American Academy of Neurology (AAN) affirms the value of this paper as an educational tool for neurologists.
Life Underwriting Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA (not licensed in New York) and John.
1. 2 PROGRAM FACULTY This program and enduring materials are aligned with Consensus Guidelines and have been developed by the Program Faculty with input.
David Holmes, et al, ACCF/AHA Clinical Alert, 2010 © 2010, American Heart Association. All rights reserved. ACCF/AHA Clopidogrel Clinical Alert: Approaches.
Eliminating Health Disparities Michael A. Rodriguez, MD, MPH Associate Professor David Geffen School of Medicine at UCLA May 10, 2006.
Better Medical Diagnostic Decisions thru Science V. Froelicher, MD Professor of Medicine Stanford University VA Palo Alto HCS Optimal Clinical Application.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Thomas Songer, PhD Introduction to Research Methods In the Internet Era Epidemiology as a Population Science Basic Epidemiology Measures Introduction to.
11 Dysphagia Screening – State of the Art Conference Proceedings from the State of the Art Nursing Symposium International Stroke Conference 2012 Neila.
Validation of the Pooled Cohort 10-year Atherosclerotic Cardiovascular Disease Risk Equations Paul Muntner, Lisandro D Colantonio, Mary Cushman, David.
Office of Rural Health Policy UPDATE and the MEDICARE BENEFICIARY QUALITY IMPROVEMENT PROJECT Paul Moore, DPh Senior Health Policy Advisor Department of.
1 Use of Cochrane review results in designing new studies Nicola Cooper Centre for Biostatistics and Genetic Epidemiology, University of Leicester UK
Harvard Medical School Hypertensive Heart Disease Gene Bukhman January 12 th, 2005.
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 ICD data.
Long Distance Titration of Heart Failure Medications by Telephone Calls Anne E. Steckler, RN, Heba Wassif, MD, Kalkidan Bishu, MD, Gardar Sigurdsson, MD,
© 2017 SlidePlayer.com Inc. All rights reserved.